Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Berner Hansen

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Gastroenterology Research and Practice|November 2, 2020
Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound HealingMarie Kjaer, Wayne Russell, Peter Schjerling, et al.
Trials|December 20, 2021
Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trialCecilie Siggaard Knoph, Mathias Ellgaard Cook, Camilla Ann Fjelsted, et al.
Gastroenterology|December 21, 2024
Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled TrialPalle B Jeppesen, Tim Vanuytsel, Sukanya Subramanian, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowelJohannes Reiner, Peggy Berlin, Jascha Held, et al.
Gastroenterology|November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative ColitisWilliam J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
Inflammatory Bowel Diseases|October 26, 2018
Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk LociKimi Drobin, Ghazaleh Assadi, Mun-Gwan Hong, et al.
BMJ Open|August 24, 2019
Characterisation of the fibroinflammatory process involved in progression from acute to chronic pancreatitis: study protocol for a multicentre, prospective cohort studySrdan Novovic, Anders Borch, Mikkel Werge, et al.
United European Gastroenterology Journal|January 19, 2026
Naldemedine for the Prevention of Recurrent Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled TrialMathias E Cook, Cecilie S Knoph, Line Davidsen, et al.
Neurogastroenterology and Motility|March 24, 2025
Gastrointestinal Transit Time Assessed Using a CT-Based Radiopaque Marker Method in Patients With Acute Pancreatitis During Methylnaltrexone TreatmentCecilie Siggaard Knoph, Andreas Svenstrup Hesthaven, Mathias Ellgaard Cook, et al.
Trials|May 1, 2023
Effects of a peripherally acting µ-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial)Mathias E Cook, Cecilie S Knoph, Camilla A Fjelsted, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Gastroenterology Research and Practice|November 2, 2020
Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound HealingMarie Kjaer, Wayne Russell, Peter Schjerling, et al.
Trials|December 20, 2021
Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trialCecilie Siggaard Knoph, Mathias Ellgaard Cook, Camilla Ann Fjelsted, et al.
Gastroenterology|December 21, 2024
Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled TrialPalle B Jeppesen, Tim Vanuytsel, Sukanya Subramanian, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 27, 2021
Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowelJohannes Reiner, Peggy Berlin, Jascha Held, et al.
Gastroenterology|November 26, 2018
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative ColitisWilliam J Sandborn, Marcoli Cyrille, Mark Berner Hansen, et al.
Inflammatory Bowel Diseases|October 26, 2018
Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk LociKimi Drobin, Ghazaleh Assadi, Mun-Gwan Hong, et al.
BMJ Open|August 24, 2019
Characterisation of the fibroinflammatory process involved in progression from acute to chronic pancreatitis: study protocol for a multicentre, prospective cohort studySrdan Novovic, Anders Borch, Mikkel Werge, et al.
United European Gastroenterology Journal|January 19, 2026
Naldemedine for the Prevention of Recurrent Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled TrialMathias E Cook, Cecilie S Knoph, Line Davidsen, et al.
Neurogastroenterology and Motility|March 24, 2025
Gastrointestinal Transit Time Assessed Using a CT-Based Radiopaque Marker Method in Patients With Acute Pancreatitis During Methylnaltrexone TreatmentCecilie Siggaard Knoph, Andreas Svenstrup Hesthaven, Mathias Ellgaard Cook, et al.
Trials|May 1, 2023
Effects of a peripherally acting µ-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial)Mathias E Cook, Cecilie S Knoph, Camilla A Fjelsted, et al.
Pageof 8